Back to DRIEHAUS CAPITAL MANAGEMENT LLC DRIEHAUS CAPITAL MANAGEMENT LLC

COAGCOAG
1 quarters

Position history for DRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC's holdings in HEMAB THERAPEUTICS HOLDI

Yes. Driehaus Capital Management holds 715,791 shares of COAG (Hemab Therapeutics Holdi), worth $26.3M, as of its Q2 2026 13F filing. COAG is 0.2% of Driehaus Capital Management's reported 13F portfolio.

Current Value

$26.3M

Current Shares

715,791

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
715,791
-
$26.3M0.2%$36.73
47

Other major holders of COAG: RA CAPITAL MANAGEMENT, L.P., FMR LLC, Capital International Investors, Avoro Capital Advisors LLC, JPMORGAN CHASE & CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used